MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q4
hinzugefügt 03.03.2026
Agilent Technologies Kurzfristige Verbindlichkeiten 2011-2026 | A
Kurzfristige Verbindlichkeiten Jährlich Agilent Technologies
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.71 B | 1.47 B | 2.08 B | 1.16 B | 1.26 B | 945 M | 976 M | 1.7 B | 1.6 B | 1.89 B | 1.84 B |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 2.08 B | 945 M | 1.51 B |
Kurzfristige Verbindlichkeiten anderer Aktien in der Diagnostik & Forschung
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Castle Biosciences
CSTL
|
68.7 M | $ 20.47 | 2.17 % | $ 593 M |  USA |
 |
Fulgent Genetics
FLGT
|
72.9 M | $ 17.3 | 5.42 % | $ 523 M | USA |
 |
Guardant Health
GH
|
303 M | $ 119.81 | 4.21 % | $ 15 B | USA |
 |
ICON Public Limited Company
ICLR
|
2.8 B | $ 114.96 | -0.11 % | $ 9.48 B |  Irlanda |
 |
Celcuity
CELC
|
44.2 M | $ 139.6 | -0.52 % | $ 6.53 B | USA |
 |
Co-Diagnostics
CODX
|
3.54 M | $ 4.01 | 67.99 % | $ 5.33 M | USA |
 |
Akumin
AKU
|
169 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
3.46 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
66.6 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
5.51 M | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
13.8 M | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
89.8 M | $ 22.14 | 4.68 % | $ 1.18 B | USA |
 |
Chembio Diagnostics
CEMI
|
39.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
4.05 M | - | - | $ 9.42 M |  Israel |
 |
Lantheus Holdings
LNTH
|
333 M | $ 94.97 | -1.17 % | $ 6.41 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
8.27 M | - | -20.0 % | $ 1.06 M | USA |
 |
Interpace Biosciences
IDXG
|
5.1 M | $ 1.8 | - | $ 7.96 M | USA |
 |
Illumina
ILMN
|
1.55 B | $ 143.09 | 0.82 % | $ 22.8 B | USA |
 |
Medpace Holdings
MEDP
|
1.34 B | $ 422.06 | 0.05 % | $ 12.2 B | USA |
 |
Mettler-Toledo International
MTD
|
1.2 B | $ 1 084.7 | 0.14 % | $ 22.4 B |  Schweiz |
 |
Global Cord Blood Corporation
CO
|
647 M | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
54.2 M | - | 1.08 % | $ 308 M | USA |
 |
Natera
NTRA
|
310 M | $ 207.46 | 1.24 % | $ 20.4 B | USA |
 |
DermTech
DMTK
|
13.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Personalis
PSNL
|
39.6 M | $ 8.51 | 7.04 % | $ 759 M | USA |
 |
Charles River Laboratories International
CRL
|
1.12 B | $ 157.83 | 1.11 % | $ 7.82 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.27 B | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
24.8 M | - | -8.98 % | $ 14.8 K | USA |
 |
NeoGenomics
NEO
|
88.3 M | $ 8.98 | 0.9 % | $ 1.15 B | USA |
 |
Exact Sciences Corporation
EXAS
|
641 M | - | - | $ 19.8 B | USA |
 |
National Research Corporation
NRC
|
36.6 M | $ 19.1 | -0.86 % | $ 428 M | USA |
 |
Myriad Genetics
MYGN
|
134 M | $ 3.8 | -0.39 % | $ 352 M | USA |
 |
Heska Corporation
HSKA
|
39.6 M | - | - | $ 1.31 B | USA |
 |
Thermo Fisher Scientific
TMO
|
15.2 B | $ 450.38 | -0.27 % | $ 170 B | USA |
 |
Senseonics Holdings
SENS
|
24.3 M | $ 5.79 | 1.4 % | $ 242 M | USA |
 |
QIAGEN N.V.
QGEN
|
512 M | - | - | $ 10.6 B |  Niderland |
 |
Soleno Therapeutics
SLNO
|
61.4 M | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
1.74 M | $ 2.42 | 2.98 % | $ 5.56 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
2.82 B | $ 253.97 | -1.3 % | $ 21.1 B | USA |
 |
Waters Corporation
WAT
|
1.24 B | $ 339.14 | -0.61 % | $ 20.2 B | USA |
 |
Twist Bioscience Corporation
TWST
|
91.4 M | $ 53.72 | 0.11 % | $ 3.21 B | USA |
 |
Motus GI Holdings
MOTS
|
3.27 M | - | -34.28 % | $ 263 K | Israel |
 |
Exagen
XGN
|
14.2 M | $ 4.11 | 7.31 % | $ 88.6 M | USA |
 |
Neogen Corporation
NEOG
|
174 M | $ 8.52 | -3.57 % | $ 1.85 B | USA |